Global Healthcare Analyst

Tina Banerjee

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/classys" target="_blank" data-smartkarma-citation="entities:29688:1" rel="noopener">Classys (214150 KS)</a> insiders have transferred 61% stake to private equity company Bain Capital for KRW670 billion. The deal values the shares at KRW17,000.</li>
<li>Bain Capital has already invested in two beauty products companies in Korea. Both of the deals remained highly profitable for Bain. Classys is Bain’s third investment in the same space.</li>
<li>Classys, with its differentiated and competitive products, is expanding its geographic presence. Consumables account for 49% of total revenue, thereby creating a stable and recurring revenue source for the company.</li>
</ul>



Classys (214150 KS) insiders have transferred 61% stake to private equity company Bain Capital for KRW670 billion. The deal values the shares at KRW17,000.
Bain Capital has already invested in two beauty products companies in Korea. Both of the deals remained highly profitable for Bain. Classys is Bain’s third investment in the same space.
Classys, with its differentiated and competitive products, is expanding its geographic presence. Consumables account for 49% of total revenue, thereby creating a stable and recurring revenue source for the company.


Classys (214150 KS): Bain Capital Deal Implies 11% Upside Potential

South Korea

Classys Inc. operates as a medical equipment manufacturing company. The Company develops and sells non surgical painless fat reduction instruments, fat freezing fat reduction instruments, and other products. Classys markets its products worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Classys (214150 KS): Bain Capital Deal Implies 11% Upside Potential

Classys share acquisition by Bain Capital at KRW17,000/share leaves 11% upside potential. Bain Capital has sold its last two investments in Korean...

Tina Banerjee